PEOPLE - Changes at Quidel (US):
This article was originally published in Clinica
Executive Summary
Quidel has announced that the following vice-presidents are leaving the company: Steven Burke, finance and administration; Glenn Holmes, marketing and sales; and Darryll Getzlaff, human resources. The US immunodiagnostics company has appointed Timothy Burke of Somatogen, a recombinant haemoglobin products developer, interim chief financial officer and Charles Bowden, a former vice-president of business development at Nellcor, has been named chief medical officer and vice-president of technology and business development.